BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23237591)

  • 1. Cultural adaptation and validation of the "Kidney Disease and Quality of Life--Short Form (KDQOL-SF™) version 1.3" questionnaire in Egypt.
    Abd ElHafeez S; Sallam SA; Gad ZM; Zoccali C; Torino C; Tripepi G; ElWakil HS; Awad NM
    BMC Nephrol; 2012 Dec; 13():170. PubMed ID: 23237591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity and reliability of the Sri Lankan version of the kidney disease quality of life questionnaire (KDQOL-SF™).
    Senanayake S; Gunawardena N; Palihawadana P; Kularatna S; Peiris TSG
    Health Qual Life Outcomes; 2017 Jun; 15(1):119. PubMed ID: 28583165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining the validity and reliability of the Chinese version of the Kidney Disease Quality of Life Questionnaire (KDQOL-36™).
    Tao X; Chow SK; Wong FK
    BMC Nephrol; 2014 Jul; 15():115. PubMed ID: 25015224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the kidney disease quality of life-short form: a cross-sectional study of a dialysis-targeted health measure in Singapore.
    Joshi VD; Mooppil N; Lim JF
    BMC Nephrol; 2010 Dec; 11():36. PubMed ID: 21172008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cultural adaptation and validation of the Filipino version of Kidney Disease Quality of Life--Short Form (KDQOL-SF version 1.3).
    Bataclan RP; Dial MA
    Nephrology (Carlton); 2009 Oct; 14(7):663-8. PubMed ID: 19796025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translation, cultural adaptation, initial reliability, and validation of the Kidney Disease and Quality of Life-Short Form (KDQOL-SF 1.3) in Turkey.
    Yildirim A; Ogutmen B; Bektas G; Isci E; Mete M; Tolgay HI
    Transplant Proc; 2007; 39(1):51-4. PubMed ID: 17275473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity and Reliability of the Indonesian Version of Kidney Disease Quality of Life (KDQOL-36) Questionnaire in Hemodialysis Patients at Hasan Sadikin Hospital, Bandung, Indonesia.
    Supriyadi R; Rakhima F; Gondodiputro RS; Darmawan G
    Acta Med Indones; 2019 Oct; 51(4):318-323. PubMed ID: 32041915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross cultural adaptation and validation of the Malay Kidney Disease Quality of Life (KDQOL-36™).
    Goh KKK; Lai PSM; Lim SK
    BMC Nephrol; 2019 Jun; 20(1):226. PubMed ID: 31221116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the English version of the Kidney Disease Quality of Life questionnaire (KDQOL-36) in haemodialysis patients in Singapore.
    Yang F; Wang VW; Joshi VD; Lau TW; Luo N
    Patient; 2013; 6(2):135-41. PubMed ID: 23613285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translation, Validation and Reliability of the Kidney Diseases Quality of Life-Short Form (KDQOL-SF Form) Tool in Urdu.
    Anees M; Ibrahim M; Imtiaz M; Batool S; Elahi I; Malik MR
    J Coll Physicians Surg Pak; 2016 Aug; 26(8):651-4. PubMed ID: 27539756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-cultural adaptation, validation and reliability of the South Indian (Kannada) version of the Kidney Disease and Quality of Life (KDQOL-36) instrument.
    Mateti UV; Nagappa AN; Attur RP; Nagaraju SP; Mayya SS; Balkrishnan R
    Saudi J Kidney Dis Transpl; 2015 Nov; 26(6):1246-52. PubMed ID: 26586066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement properties of the Chinese Version of the Kidney Disease Quality of Life-Short Form (KDQOL-SF™) in end-stage renal disease patients with poor prognosis in Singapore.
    Cheung YB; Seow YY; Qu LM; Yee AC
    J Pain Symptom Manage; 2012 Dec; 44(6):923-32. PubMed ID: 22795902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cultural adaptation and validation of the "Kidney Disease and Quality of Life--Short Form (KDQOL-SF 1.3)" in Brazil.
    Duarte PS; Ciconelli RM; Sesso R
    Braz J Med Biol Res; 2005 Feb; 38(2):261-70. PubMed ID: 15785838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translation, cultural adaptation, and initial reliability and multitrait testing of the Kidney Disease Quality of Life instrument for use in Japan.
    Green J; Fukuhara S; Shinzato T; Miura Y; Wada S; Hays RD; Tabata R; Otsuka H; Takai I; Maeda K; Kurokawa K
    Qual Life Res; 2001; 10(1):93-100. PubMed ID: 11508479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arabic validation and cross-cultural adaptation of the 5C scale for assessment of COVID-19 vaccines psychological antecedents.
    Abd ElHafeez S; Elbarazi I; Shaaban R; ElMakhzangy R; Ossama Aly M; Alnagar A; Yacoub M; El Saeh HM; Eltaweel N; Alqutub ST; Mohamed Ghazy R
    PLoS One; 2021; 16(8):e0254595. PubMed ID: 34437554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cultural adaptation and validation of the Systemic Sclerosis Quality of Life questionnaire into Arabic language.
    Alian SM; Sherby NA; Sarhan SA
    Clin Rheumatol; 2021 Apr; 40(4):1409-1416. PubMed ID: 32918142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Disease-Specific Components of the Kidney Disease Quality of Life-36 (KDQOL-36) in Chinese Patients Undergoing Maintenance Dialysis.
    Chen JY; Choi EP; Wan EY; Chan AK; Tsang JP; Chan KH; Lo WK; Lui SL; Chu WL; Lam CL
    PLoS One; 2016; 11(5):e0155188. PubMed ID: 27148742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychometric Properties of the Kidney Disease Quality of Life 36-Item Short-Form Survey (KDQOL-36) in the United States.
    Peipert JD; Bentler PM; Klicko K; Hays RD
    Am J Kidney Dis; 2018 Apr; 71(4):461-468. PubMed ID: 29128411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translation, cultural adaptation, and validation of the Integrated Palliative Outcome Scale-renal (IPOS-r) to Czech.
    Křemenová Z; Vlčková K
    BMC Palliat Care; 2022 Aug; 21(1):152. PubMed ID: 36038854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric properties of the kidney disease quality of life-36 (KDQOL-36) in Ethiopian patients undergoing hemodialysis.
    Gebrie MH; Asfaw HM; Bilchut WH; Lindgren H; Wettergren L
    Health Qual Life Outcomes; 2022 Feb; 20(1):24. PubMed ID: 35144625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.